News

A series of awards granted to scientists under the age of 45 has been announced by the Association for Research in Vision and Ophthalmology (ARVO) Foundation for Eye Research (AFER) and Merck & Co, Inc.

The difficulty of accurate IOL power calculation in postLASIK eyes is an issue being faced increasingly by cataract surgeons. Jack T. Holladay, MD, clinical professor of ophthalmology, Baylor College of Medicine, Houston, Texas, US offered several tips for achieving better refractive outcomes in this growing population of eyes.

Long-term use of anti-vascular endothelial growth factor (VEGF) drugs should be treated with caution because endogenous VEGF plays an important role in the maintenance of retina neuronal cells, according to study results published by PLoS ONE on the 3rd November.

The slimmer design of 25 G instruments has left us exposed to an increased risk of complications and decreased surgical control.

The Phase I three-year feasibility study of the Argus II Retinal Implant for Retinitis Pigmentosa (RP) will be expanded to enrol more patients in Europe, according to an announcement from Second Sight Medical Products, the implant's manufacturer.

Although there is a relatively high rate of diabetic retinopathy (DR) progressing to proliferative diabetic retinopathy (PDR), the level of PDR care available has improved, according to 25-year results of the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR), published in the November issue of Ophthalmology.

It may be possible to regenerate optic neural axons by manipulating growth control pathways, according to study results published in the 7 November issue of the journal Science.

GS-101, Gene Signal's experimental topical ophthalmic solution designed to prevent the rejection of corneal grafts, has entered Phase III trials.

Instead of combined surgery, cataract extraction alone by phacoemulsification through a clear corneal incision with posterior chamber IOL implantation may be the most appropriate procedure for patients with controlled or modestly uncontrolled glaucoma as well as for patients with ocular hypertension or glaucoma suspects.

The holiday season is upon us again and we are about to close the door on another year, but before we do, I would firstly like to say a big thank you to all of you for your continued support of our publication throughout this year.

Office-based vergence/accommodative therapy with home reinforcement (OBVAT) is the most effective method of treating symptomatic convergence insufficiency when compared with any other home- or office-based placebo or therapy, according to study results published in the October issue of the Archives of Ophthalmology.

A series of debates on the most relevant, and most controversial, topics in ophthalmology, in which today's most eminent ophthalmologists argue for the validity of their differing opinions and practices.

HOYA Surgical Optics has been distributing IOLs to ophthalmic surgeons in Europe since 2003. The name HOYA, however, represents more than just IOLs; the firm has a long tradition in high tech optics…

Laser in situ keratomileusis buttonhole: Classification and management algorithm

x

Clinical findings following Ahmed Glaucoma Valve implantation in pediatric glaucoma

The Phase I three-year feasibility study of the Argus II Retinal Implant for Retinitis Pigmentosa (RP) will be expanded to enrol more patients in Europe, according to an announcement from Second Sight Medical Products, the implant's manufacturer.

An ophthalmology network, aiming to prevent loss of vision across the country, has been established in Wales.

The growing understanding that glaucoma is a neurodegenerative rather than ocular disease is to be the principal topic of discussion of the annual Glaucoma Research Foundation (GRF) benefit, to be held January 28 2009 in San Francisco, California, US.

The methods used to manage glaucoma vary widely across the United Kingdom, according to study results published in the November issue of Eye.

Risk Factors for Retinal Hemorrhage after Photodynamic Therapy in Age-Related Macular Degeneration

STAAR Surgical has created the Collamer Accommodating Study Team (CAST), a group of seven ophthalmologists who will investigate the accommodative properties of STAAR's Collamer intraocular lens (IOL).

The Phase IIb trial assessing the safety and efficacy of microplasmin in patients, showed complete resolution of vitreomacular traction or macular hole without need for vitrectomy surgery, according to a statement from the trial sponsor, ThromboGenics NV.

Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy

A Comparison of the Glaucoma Probability Score to Earlier Heidelberg Retina Tomograph Data Analysis Tools in Classifying Normal and Glaucoma Patients

Topcon Medical Systems has introduced new OCT mapping software and enhanced its image management system.

Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study

23-gauge versus 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial

A cleaning solution for silicone intraocular lenses: "sticky silicone oil"

Contact anaesthesia is just as safe and effective as peribulbar application for combined cataract and glaucoma surgery, according to study results published online ahead of print by Ophthalmologica.